1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Jena Acquisition Corp II, a Cayman Islands blank check company, received a written notice on April 1, 2026 from NYSE Regulation stating it does not meet the requirement to maintain at least 300 public shareholders on a continuous basis. The company plans to submit a business plan to NYSE within 45 days showing how it will regain compliance within 18 months, and says the notice has no immediate effect on its listing or trading. For shareholders, the securities remain listed for now, but continued listing during the cure period depends on NYSE approving the plan.
Notice received April 1, 2026 from NYSE Regulation under the 300 public shareholder minimum.
Business plan due within 45 days of receipt; NYSE then has 45 days to review it.
Press release says the plan will involve completing a de-SPAC transaction; the 8-K cites Section 802.01A while the press release cites Section 802.01B.
On March 30, 2026, Crown Reserve Acquisition Corp. I (CRAC) signed a Business Combination Agreement with Carvix, Inc., a Delaware corporation, under which Carvix would merge into a subsidiary of the SPAC and survive as a wholly owned subsidiary. Carvix stockholders would receive 50,000,001 SPAC common shares at closing, plus up to 50,000,100 earnout shares over four years, which would dilute existing SPAC shareholders.
Agreement signed March 30, 2026, with Carvix, Inc.; the SPAC would first domesticate to Delaware.
Carvix stockholders to receive 50,000,001 shares at the Effective Time, plus up to 50,000,100 earnout shares.
Earnout split equally between EBITDA targets (first year $10.38 million) and revenue targets (first year $276.8 million), with payment years starting January 1, 2027.
Either party may terminate if closing has not occurred by September 30, 2026, the Outside Date.
Drugs Made In America Acquisition II Corp. entered into a definitive agreement with Alpha Multi Family Office for a contemplated $1,400,000 convertible notes financing, following a $150,000 bridge loan issued March 11, 2026. The company also issued a $300,000 interim convertible note on March 30, 2026, which is a direct financial obligation and can convert into shares of the combined company after a business combination at a 35% discount to market.
Definitive Investment and Sponsor Transition Agreement effective March 24, 2026, for a contemplated $1,400,000 convertible notes financing
Interim Convertible Note of $300,000 issued March 30, 2026, with a maturity of nine months and no interest
Note converts after the initial business combination at a 35% discount to market price, at the investor's option
Proceeds to fund accounting, audit and other expenses related to the business combination
AbbVie said its first-quarter 2026 results will include $744 million in pre-tax acquired IPR&D and milestones expense, reducing both GAAP and adjusted diluted EPS by $0.41. Full-year 2026 adjusted EPS guidance falls to $13.96-$14.16 from the $14.37-$14.57 range given on February 4, 2026, and AbbVie says its guidance excludes any such expense incurred after the first quarter. Shareholders face a lower earnings outlook, and the quarter's results have not been finalized.
Q1 2026 acquired IPR&D and milestones expense of $744 million pre-tax, an unfavorable $0.41 impact on GAAP and adjusted diluted EPS
Full-year 2026 adjusted diluted EPS guidance now $13.96-$14.16, versus $14.37-$14.57 previously
Q1 2026 adjusted diluted EPS guidance now $2.56-$2.60, versus $2.97-$3.01 before the charge
Quarter ended March 31, 2026 results not finalized and may differ from these preliminary estimates
On March 31, 2026, BlackRock and certain subsidiaries entered into Amendment No. 17 to its Five-Year Revolving Credit Agreement with Wells Fargo Bank, National Association, as administrative agent. The amendment increases total revolving commitments by $400 million to $6.3 billion, extends the maturity for most lenders to March 31, 2031, and removes the SOFR adjustment for SOFR-based loans.
Aggregate revolving commitment increased by $400 million to $6.3 billion
Maturity extended to March 31, 2031 for lenders other than two non-extending lenders
Commitment of the two non-extending lenders matures on March 31, 2028
SOFR adjustment removed for all SOFR-based loans; other existing terms unchanged
Agilent said Senior Vice President, Chief Legal Officer and Secretary Bret DiMarco signed a transition and general release agreement on March 31, 2026. He will resign from those roles when a new Chief Legal Officer starts or on September 30, 2026, whichever is earlier, and will serve as a Special Advisor through December 1, 2026. The filing gives no financial results, and the change affects one senior legal officer role.
Agreement dated March 31, 2026; resignation occurs on the earlier of a new Chief Legal Officer's start date or September 30, 2026
Special Advisor role runs through December 1, 2026, at an annualized base salary of $350,000
No additional equity grants or 2026 fiscal year annual bonus; existing equity awards continue vesting
Lump sum payment equal to one times base salary and target bonus, less advisor salary paid, subject to a supplemental release of claims
RCM Technologies reported results for the fourteen-week fourth quarter and fifty-three-week fiscal year ended January 3, 2026. Revenue, GAAP net income and diluted earnings per share all rose from the prior year, and the company said it would not hold a conference call on the results.
Fiscal year revenue was $319.4 million, up 14.7% from $278.4 million, with GAAP net income of $16.3 million, or $2.14 per diluted share, versus $1.68 a year earlier.
Fourth-quarter revenue was $86.5 million, up 12.4% from $76.9 million, with GAAP net income of $6.1 million, or $0.80 per diluted share, versus $0.37.
Fiscal year adjusted EBITDA (non-GAAP) was $30.7 million, up 18.9%; adjusted diluted EPS (non-GAAP) was $2.50 versus $2.03.
The fourth quarter covered fourteen weeks, compared with thirteen weeks in the prior-year quarter.
On March 30, 2026, Future Money Acquisition Corp, a blank check company, closed its initial public offering of 11,200,000 units at $10.00 each, for gross proceeds of $112 million, and sold 304,000 private placement units to its sponsor for $3.04 million. The company placed $112.56 million, or $10.05 per unit, in a trust account, and its auditor included a going concern paragraph citing the 15-month deadline to complete a business combination.
IPO of 11,200,000 units at $10.00 per unit, generating $112,000,000 in gross proceeds, closed March 30, 2026
Private placement of 304,000 units to sponsor Future Wealth Capital Corp for $3,040,000
$112,560,000 ($10.05 per unit) placed in trust account with Equiniti Trust Company, LLC; company has until June 30, 2027 to complete a business combination
Auditor HYYH CPA, LLC cited substantial doubt about the company's ability to continue as a going concern
U.S. Gold Corp. reported results of a Feasibility Study for its wholly owned CK Gold Project in Wyoming, showing a 27% after-tax IRR and $394 million initial capital cost at base case metal prices. The study reports 931 koz AuEq of payable metal over an 11-year mine life, and the company says all permits to begin construction are in hand. For shareholders, the study is a technical and economic assessment; the filing does not report revenue, earnings, or a financing plan, and construction depends on securing project financing.
After-tax NPV (5%) of $632 million and after-tax IRR of 27% at base case prices of $3,250/oz gold, $4.50/lb copper and $40/oz silver
Initial capital cost of $394 million, plus $28 million of preproduction owners' costs and $35 million of sustaining capital over the mine life
Payback period of 2.5 years at base case prices; company says all permits to begin construction are in hand
Conference call and webcast scheduled for Wednesday, April 1, 2026 at 4:00 PM Eastern Time
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.